Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Avita Medical Inc. (RCEL : NSDQ)

• Company Description    AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif. Number of Employees: 226

• Price / Volume Information    Yesterday's Closing Price: $4.58 Daily Weekly Monthly 20 Day Moving Average: 258,193 shares Shares Outstanding: 30.78 (millions) Market Capitalization: $140.96 (millions) Beta: 1.90 52 Week High: $7.12 52 Week Low: $3.22 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.77% 0.61% 12 Week -10.37% -17.14% Year To Date 32.75% 19.39%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 28159 Avenue Stanford Suite 220 - Valencia,CA 91355 USA ph: 661-367-9170 fax: - investor@avitamedical.com http://www.avitamedical.com

• General Corporate Information    Officers Cary Vance - Chief Executive Officer and Executive Chairman of David O Toole - Chief Financial Officer Jan Stern Reed - Director Jeremy Curnock Cook - Director Robert McNamara - Director Peer Information Avita Medical Inc. (GSAC) Avita Medical Inc. (CASIF) Avita Medical Inc. (ALCD.) Avita Medical Inc. (OMNN) Avita Medical Inc. (CGPI.) Avita Medical Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 05380C102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 30.78 Most Recent Split Date: 6.00 (0.20:1) Beta: 1.90 Market Capitalization: $140.96 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.28 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.95 EPS Growth vs. Year Ago Period: 33.96% vs. Previous Quarter: 7.89% Sales Growth vs. Year Ago Period: 3.98% vs. Previous Quarter: 9.28% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - -78.92 12/31/25 - -78.43 09/30/25 - -71.64 Current Ratio 03/31/26 - 0.47 12/31/25 - 0.57 09/30/25 - 0.67 Quick Ratio 03/31/26 - - 12/31/25 - 0.46 09/30/25 - 0.55 Operating Margin 03/31/26 - -62.67 12/31/25 - -67.85 09/30/25 - -67.07 Net Margin 03/31/26 - -62.67 12/31/25 - -67.85 09/30/25 - -67.07 Pre-Tax Margin 03/31/26 - -62.68 12/31/25 - -67.83 09/30/25 - -67.00 Book Value 03/31/26 - -0.75 12/31/25 - -0.55 09/30/25 - -0.25 Inventory Turnover 03/31/26 - 1.94 12/31/25 - 1.70 09/30/25 - 1.55 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©